Malvinder Mohan Singh sold off his family-run pharma business Ranbaxy for a whooping USD 4.8 billion. Today, he is heading Religare Financial Services and Fortis Healthcare Services.Young Turks finds out Malvinder Singh’s strategy for success and what he has planned for the future.
first published: May 21, 2011 02:04 pm
A collection of the most-viewed Moneycontrol videos.
Infosys Q2 Earnings Live | Decoding Infosys Q2 Earnings | Earnings Express
Indian stocks Vs Gold, Silver, Global equities: Manish Chokhani on where to sow, where to harvest
Can Nifty Reclaim 25,400 After Strong Comeback; Infosys, Axis, Eternal In Focus|Opening Bell Live
Sensex, Nifty resume rally after 2-day pause, financials shine bright | Closing Bell
